Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Natural Alternatives International(NAII)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for NAII
10/26/2026: NAII (1-star) is currently NOT-A-BUY. Pass it for now.
Natural Alternatives International is a specialized manufacturer and ingredient licensor serving the global nutrition industry. Its primary strength lies in its patented CarnoSyn® beta-alanine technology, which provides a high-margin, scalable royalty stream alongside its contract manufacturing business. While the company benefits from long-term client relationships and a conservative financial profile, it faces significant risks from customer concentration and the cyclical nature of the direct-selling channel. The investment story centers on diversifying its customer base and the potential for wider adoption of its proprietary ingredients. It may suit value-oriented investors seeking stable operations, though monitoring contract wins and client health is essential for assessing future performance.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Growth is largely dependent on client successes rather than rapid independent expansion. |
| Momentum investor | Weak fit | The stock often lacks the sustained high-volume trading and upward price trends required for momentum strategies. |
| Value investor | Strong fit | NAI often trades at valuations that may appeal to investors looking for cash-generative, small-cap assets. |
| Dividend investor | Strong fit while signal remains positive | The company has a history of returning capital to shareholders through dividends when earnings permit. |
| Low-risk investor | Mixed fit | While the business is established, its reliance on a few large clients introduces significant revenue concentration risk. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | Small-cap stocks in the supplement sector can experience significant price swings based on contract wins or losses. |
| Valuation risk | Medium | Investors must ensure the stock price adequately reflects the cyclical nature of its primary customer base. |
| Competition risk (Contract manufacturing competition) | High | Intense competition from low-cost manufacturers puts persistent pressure on margins. |
| Business quality | Medium | The business benefits from strong intellectual property but faces concentration risks with key partners. |
| Dividend income | Medium | Dividend payments are not guaranteed and are contingent upon the company's financial performance. |
| Execution risk | Medium | Operational delays or supply chain disruptions in manufacturing can directly impact quarterly earnings. |
Price Behavior
Steep Decline
The stock price has dropped sharply with strong downward pressure.
Highly Choppy
The stock has experienced frequent, large price swings that make its near-term movement less predictable.
Analysis of Past Performance
Type Stock | Historic Profit -45.42% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/26/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.20M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) 25.9K shares | Beta 0.35 | 52 Weeks Range 1.08 - 4.96 | Updated Date 10/26/2026 |
52 Weeks Range 1.08 - 4.96 | Updated Date 10/26/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.43 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Contract Manufacturing | Manufacturing and packaging of nutritional supplements for third-party brands. | This is the core of their business, generating revenue by producing supplements for other companies. |
| Licensing & Royalties | Royalty payments from the use of patented ingredients like CarnoSyn®. | This provides a higher-margin stream of income based on the success of their scientific research. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 13.61 | Enterprise Value 50.17M | Price to Sales(TTM) 0.05 |
Enterprise Value 50.17M | Price to Sales(TTM) 0.05 | ||
Enterprise Value to Revenue 0.35 | Enterprise Value to EBITDA 74.97 | Shares Outstanding 6.26M | Shares Floating 4.73M |
Shares Outstanding 6.26M | Shares Floating 4.73M | ||
Percent Insiders 21.4 | Percent Institutions 36.4 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.